In Ad5 pre-immunized mice, repeated immunizations with Ad5 [E1-, E2b-]-CEA were compared to current generation Ad5 [E1-]-CEA for CEA immunogenicity and in vivo anti-tumor effects. This evidence concerns the gene CEACAM5 and neoplasm.